What is the recommended treatment for chlamydia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Chlamydia

For uncomplicated genital chlamydia, treat with either azithromycin 1 g orally as a single dose or doxycycline 100 mg orally twice daily for 7 days, both achieving 97-98% cure rates. 1, 2

First-Line Treatment Selection

Both regimens are equally effective for uncomplicated genital chlamydia, but selection depends on specific clinical circumstances:

Azithromycin 1 g single dose is preferred when: 1, 2

  • Compliance with multi-day regimens is questionable 1
  • Treating young adults with erratic health-care-seeking behavior 1
  • Directly observed therapy is desired to maximize compliance 1, 2
  • Follow-up is unpredictable, making it more cost-effective 1

Doxycycline 100 mg twice daily for 7 days is preferred when: 1, 2

  • Cost is a primary concern (doxycycline is less expensive) 1, 2
  • Patient has reliable follow-up and good medication adherence 2
  • Treating rectal chlamydia (see special considerations below) 3

Alternative Treatment Options

If first-line medications cannot be used, alternatives include: 1, 2

  • Erythromycin base 500 mg orally four times daily for 7 days 1, 2
  • Erythromycin ethylsuccinate 800 mg orally four times daily for 7 days 1, 2
  • Ofloxacin 300 mg orally twice daily for 7 days 1, 2
  • Levofloxacin 500 mg orally once daily for 7 days 1, 2

Important caveat: Erythromycin causes significant gastrointestinal side effects leading to poor compliance, making it a less desirable alternative. 2

Treatment During Pregnancy

Doxycycline and ofloxacin are absolutely contraindicated during pregnancy. 1, 4

Recommended options for pregnant patients: 1, 2

  • Azithromycin 1 g orally as a single dose (preferred) 1, 4
  • Amoxicillin 500 mg orally three times daily for 7 days 1, 2
  • Erythromycin base 500 mg orally four times daily for 7 days 2

Pediatric Dosing

For children ≥8 years weighing >45 kg: 1

  • Azithromycin 1 g orally as a single dose, OR
  • Doxycycline 100 mg orally twice daily for 7 days 1

For children ≥8 years weighing <45 kg: 1

  • Weight-based dosing: 2 mg/kg divided into two doses on day 1, then 1 mg/kg daily 5

For children <8 years or <45 kg: 1

  • Erythromycin base or ethylsuccinate 50 mg/kg/day orally divided into four doses daily for 14 days 1

Critical warning: Avoid non-culture tests (EIA, DFA) in children due to false-positive results from cross-reaction with other organisms. 1

Special Considerations for Rectal Chlamydia

Doxycycline is significantly more effective than azithromycin for rectal chlamydia infections. 3

  • Azithromycin efficacy for rectal chlamydia: 82.9% (95% CI 76.0%-89.8%) 3
  • Doxycycline efficacy for rectal chlamydia: 99.6% (95% CI 98.6%-100%) 3
  • This represents a 19.9% efficacy difference favoring doxycycline 3

For men who have sex with men with rectal chlamydia, strongly prefer doxycycline 100 mg twice daily for 7 days over azithromycin. 3

Implementation Best Practices

Medication dispensing and administration: 1, 2

  • Dispense medications on-site when possible 1, 2
  • Directly observe the first dose to maximize compliance 1, 2
  • Administer with adequate fluids to reduce esophageal irritation risk 5
  • Doxycycline may be given with food or milk if gastric irritation occurs 5

Sexual activity restrictions: 1

  • Patients must abstain from all sexual intercourse for 7 days after initiating treatment 1
  • Continue abstinence until all sex partners have been treated 1, 2

Partner Management

All sex partners from the previous 60 days must be evaluated, tested, and treated empirically. 1, 2

  • If last sexual contact was >60 days before diagnosis, still treat the most recent partner 1, 2
  • Partner treatment is critical to prevent reinfection 1

Additional STI Testing

At the initial visit, test all chlamydia-positive patients for: 1

  • Gonorrhea (coinfection is common; treat presumptively if gonorrhea is present) 1
  • Syphilis 1
  • HIV 1

Follow-Up Recommendations

Test-of-cure is NOT recommended for patients who: 1, 2

  • Received recommended treatment regimens 1, 2
  • Are asymptomatic 1
  • Have reliable therapeutic compliance 1, 2

Test-of-cure IS recommended when: 1, 2

  • Therapeutic compliance is questionable 1, 2
  • Symptoms persist 1, 2
  • Reinfection is suspected 1, 2

Repeat testing at 3 months post-treatment is strongly recommended due to high reinfection rates, particularly in women. 1, 2

Common Pitfalls to Avoid

  • Never use azithromycin as first-line for rectal chlamydia - treatment failure rates are unacceptably high at 17.1% 3
  • Never prescribe doxycycline during pregnancy - it is absolutely contraindicated 1, 4
  • Never rely on patient-reported compliance - dispense on-site and observe first dose when possible 1, 2
  • Never skip partner treatment - this is the leading cause of reinfection 1
  • Never use non-culture tests in children - false positives are common 1
  • Never forget to test for concurrent STIs - gonorrhea coinfection is common and requires additional treatment 1

References

Guideline

Chlamydia Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Chlamydia Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment for Combined Chlamydia and Bacterial Vaginosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.